Skip to main content
Clinical Trials/NCT06087224
NCT06087224RecruitingNot Applicable

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Mayo Clinic64 sites in 2 countries947 target enrollmentStarted: March 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
947
Locations
64
Primary Endpoint
7-day mortality rate

Study Overview

Brief Summary

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

Detailed Description

This prospective, multicenter trial will use a stepped wedge cluster randomized study design to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed "teleneonatology") on the risk of early mortality, early morbidity, and delivery room care for at-risk neonates delivered in community hospitals.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
0 Days to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •GROUP 1: Community hospital clinicians
  • •To be eligible to participate in this study, an individual must meet all of the following criteria:
  • •A clinician who attends newborn resuscitations at a participating community hospital spoke site.
  • •Provision of informed oral consent prior to any mandatory study specific procedures and analyses.
  • •GROUP 2: At-risk outborn neonates To be eligible for this study, a neonate born in a participating community hospital spoke site must meet *at least one* of the following inclusion criteria
  • •Preterm birth at less than 32 weeks' gestation at delivery; OR
  • •Need for advanced resuscitation defined as:
  • •positive pressure ventilation (PPV) initiated soon after birth and continued for at least 10 minutes; OR
  • •placement of an alternative airway (endotracheal tube or laryngeal mask) to provide PPV; OR
  • •chest compressions.

Exclusion Criteria

  • •GROUP 1: Community hospital clinicians None
  • •GROUP 2: At-risk outborn neonates
  • •A neonate born in a participating community hospital spoke site who meets any of the following criteria will be excluded from the study:
  • •Birth outside of the hospital birthing center.
  • •Neonatal transport team present at time of birth and providing resuscitative care.
  • •Severe congenital anomaly necessitating intensive care or surgery in the first two weeks of life.
  • •Plan for comfort care (non-resuscitation) following delivery.
  • •In-person neonatology-trained physician present for the resuscitation.

Arms & Interventions

Teleneonatology group

Experimental

Study eligible neonates cared for by the community hospital team with telemedicine consultation by a neonatologist from the regional neonatal intensive care unit (NICU).

Intervention: Teleneonatology (Other)

Control group

No Intervention

Study eligible neonates cared for by the community hospital team per the site's usual practice of care.

Outcomes

Primary Outcomes

7-day mortality rate

Time Frame: 7 days

Percentage of neonates classified as dying within 7 days, defined as death on or before 23:59 on the seventh completed day of life.

Secondary Outcomes

  • Early neonatal morbidity within the first 7 days(7 days)
  • Highest level of resuscitation received in the delivery room(First hour of life)
  • Composite outcome of early mortality and morbidity(7 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jennifer L. Fang

Principal Investigator

Mayo Clinic

Study Sites (64)

Loading locations...

Similar Trials